nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—esophageal cancer—Barrett's esophagus	0.367	0.595	CtDrD
Methotrexate—stomach cancer—Barrett's esophagus	0.25	0.405	CtDrD
Methotrexate—ABCC3—Omeprazole—Barrett's esophagus	0.145	0.641	CbGbCtD
Methotrexate—ABCG2—Omeprazole—Barrett's esophagus	0.0597	0.264	CbGbCtD
Methotrexate—ABCB1—Omeprazole—Barrett's esophagus	0.0215	0.095	CbGbCtD
Methotrexate—FOLR1—exocrine gland—Barrett's esophagus	0.00543	0.161	CbGeAlD
Methotrexate—ABCC2—bile—Barrett's esophagus	0.00413	0.123	CbGeAlD
Methotrexate—FOLR1—epithelium—Barrett's esophagus	0.00236	0.0701	CbGeAlD
Methotrexate—Nodule—Esomeprazole—Barrett's esophagus	0.00195	0.0205	CcSEcCtD
Methotrexate—Nodule—Omeprazole—Barrett's esophagus	0.00195	0.0205	CcSEcCtD
Methotrexate—Allergic cutaneous angiitis—Omeprazole—Barrett's esophagus	0.00181	0.0189	CcSEcCtD
Methotrexate—Allergic cutaneous angiitis—Esomeprazole—Barrett's esophagus	0.00181	0.0189	CcSEcCtD
Methotrexate—SLC19A1—digestive system—Barrett's esophagus	0.00158	0.0468	CbGeAlD
Methotrexate—GGH—smooth muscle tissue—Barrett's esophagus	0.00151	0.0449	CbGeAlD
Methotrexate—ATIC—epithelium—Barrett's esophagus	0.00133	0.0396	CbGeAlD
Methotrexate—ATIC—smooth muscle tissue—Barrett's esophagus	0.00129	0.0382	CbGeAlD
Methotrexate—Ulcerative stomatitis—Omeprazole—Barrett's esophagus	0.00124	0.013	CcSEcCtD
Methotrexate—Ulcerative stomatitis—Esomeprazole—Barrett's esophagus	0.00124	0.013	CcSEcCtD
Methotrexate—SLC46A1—digestive system—Barrett's esophagus	0.00121	0.036	CbGeAlD
Methotrexate—GGH—digestive system—Barrett's esophagus	0.00119	0.0354	CbGeAlD
Methotrexate—Leukocytoclastic vasculitis—Omeprazole—Barrett's esophagus	0.00117	0.0123	CcSEcCtD
Methotrexate—Leukocytoclastic vasculitis—Esomeprazole—Barrett's esophagus	0.00117	0.0123	CcSEcCtD
Methotrexate—FPGS—digestive system—Barrett's esophagus	0.00105	0.0312	CbGeAlD
Methotrexate—ATIC—digestive system—Barrett's esophagus	0.00102	0.0301	CbGeAlD
Methotrexate—Multiple fractures—Esomeprazole—Barrett's esophagus	0.000988	0.0103	CcSEcCtD
Methotrexate—Fracture—Esomeprazole—Barrett's esophagus	0.000988	0.0103	CcSEcCtD
Methotrexate—Multiple fractures—Omeprazole—Barrett's esophagus	0.000988	0.0103	CcSEcCtD
Methotrexate—Fracture—Omeprazole—Barrett's esophagus	0.000988	0.0103	CcSEcCtD
Methotrexate—Polyp—Esomeprazole—Barrett's esophagus	0.000944	0.00988	CcSEcCtD
Methotrexate—Polyp—Omeprazole—Barrett's esophagus	0.000944	0.00988	CcSEcCtD
Methotrexate—Eruption—Esomeprazole—Barrett's esophagus	0.000934	0.00977	CcSEcCtD
Methotrexate—Eruption—Omeprazole—Barrett's esophagus	0.000934	0.00977	CcSEcCtD
Methotrexate—Encephalopathy—Esomeprazole—Barrett's esophagus	0.000895	0.00937	CcSEcCtD
Methotrexate—Encephalopathy—Omeprazole—Barrett's esophagus	0.000895	0.00937	CcSEcCtD
Methotrexate—TYMS—smooth muscle tissue—Barrett's esophagus	0.000872	0.0259	CbGeAlD
Methotrexate—Cyst—Omeprazole—Barrett's esophagus	0.000859	0.00899	CcSEcCtD
Methotrexate—Cyst—Esomeprazole—Barrett's esophagus	0.000859	0.00899	CcSEcCtD
Methotrexate—Liver disorder—Omeprazole—Barrett's esophagus	0.000843	0.00882	CcSEcCtD
Methotrexate—Liver disorder—Esomeprazole—Barrett's esophagus	0.000843	0.00882	CcSEcCtD
Methotrexate—PGD—smooth muscle tissue—Barrett's esophagus	0.00083	0.0246	CbGeAlD
Methotrexate—SLC22A11—digestive system—Barrett's esophagus	0.00082	0.0243	CbGeAlD
Methotrexate—SLC16A1—epithelium—Barrett's esophagus	0.000804	0.0239	CbGeAlD
Methotrexate—SLC22A7—digestive system—Barrett's esophagus	0.0008	0.0237	CbGeAlD
Methotrexate—MTHFR—digestive system—Barrett's esophagus	0.000755	0.0224	CbGeAlD
Methotrexate—Fungal infection—Esomeprazole—Barrett's esophagus	0.000744	0.00779	CcSEcCtD
Methotrexate—Fungal infection—Omeprazole—Barrett's esophagus	0.000744	0.00779	CcSEcCtD
Methotrexate—Necrosis—Esomeprazole—Barrett's esophagus	0.000732	0.00766	CcSEcCtD
Methotrexate—Necrosis—Omeprazole—Barrett's esophagus	0.000732	0.00766	CcSEcCtD
Methotrexate—Petechiae—Esomeprazole—Barrett's esophagus	0.000698	0.00731	CcSEcCtD
Methotrexate—Petechiae—Omeprazole—Barrett's esophagus	0.000698	0.00731	CcSEcCtD
Methotrexate—TYMS—digestive system—Barrett's esophagus	0.000689	0.0204	CbGeAlD
Methotrexate—DHFR—digestive system—Barrett's esophagus	0.000682	0.0202	CbGeAlD
Methotrexate—PGD—digestive system—Barrett's esophagus	0.000656	0.0194	CbGeAlD
Methotrexate—Proteinuria—Omeprazole—Barrett's esophagus	0.000654	0.00684	CcSEcCtD
Methotrexate—Proteinuria—Esomeprazole—Barrett's esophagus	0.000654	0.00684	CcSEcCtD
Methotrexate—Protein urine present—Esomeprazole—Barrett's esophagus	0.000645	0.00675	CcSEcCtD
Methotrexate—Protein urine present—Omeprazole—Barrett's esophagus	0.000645	0.00675	CcSEcCtD
Methotrexate—Bone disorder—Omeprazole—Barrett's esophagus	0.000636	0.00666	CcSEcCtD
Methotrexate—Bone disorder—Esomeprazole—Barrett's esophagus	0.000636	0.00666	CcSEcCtD
Methotrexate—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.000632	0.00661	CcSEcCtD
Methotrexate—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.000632	0.00661	CcSEcCtD
Methotrexate—Glossitis—Omeprazole—Barrett's esophagus	0.000623	0.00652	CcSEcCtD
Methotrexate—Glossitis—Esomeprazole—Barrett's esophagus	0.000623	0.00652	CcSEcCtD
Methotrexate—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.000619	0.00648	CcSEcCtD
Methotrexate—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.000619	0.00648	CcSEcCtD
Methotrexate—SLC16A1—digestive system—Barrett's esophagus	0.000612	0.0182	CbGeAlD
Methotrexate—Hepatic enzyme increased—Esomeprazole—Barrett's esophagus	0.000607	0.00636	CcSEcCtD
Methotrexate—Hepatic enzyme increased—Omeprazole—Barrett's esophagus	0.000607	0.00636	CcSEcCtD
Methotrexate—SLCO1B1—digestive system—Barrett's esophagus	0.000595	0.0177	CbGeAlD
Methotrexate—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.000585	0.00612	CcSEcCtD
Methotrexate—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.000585	0.00612	CcSEcCtD
Methotrexate—AOX1—digestive system—Barrett's esophagus	0.000578	0.0171	CbGeAlD
Methotrexate—Vaginal inflammation—Esomeprazole—Barrett's esophagus	0.000574	0.00601	CcSEcCtD
Methotrexate—Vaginal inflammation—Omeprazole—Barrett's esophagus	0.000574	0.00601	CcSEcCtD
Methotrexate—ABCC3—digestive system—Barrett's esophagus	0.000565	0.0168	CbGeAlD
Methotrexate—ABCC10—digestive system—Barrett's esophagus	0.000562	0.0167	CbGeAlD
Methotrexate—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.000561	0.00587	CcSEcCtD
Methotrexate—Melaena—Omeprazole—Barrett's esophagus	0.000561	0.00587	CcSEcCtD
Methotrexate—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.000561	0.00587	CcSEcCtD
Methotrexate—Melaena—Esomeprazole—Barrett's esophagus	0.000561	0.00587	CcSEcCtD
Methotrexate—Cystitis—Omeprazole—Barrett's esophagus	0.000555	0.00581	CcSEcCtD
Methotrexate—Cystitis—Esomeprazole—Barrett's esophagus	0.000555	0.00581	CcSEcCtD
Methotrexate—Vaginal infection—Omeprazole—Barrett's esophagus	0.000542	0.00568	CcSEcCtD
Methotrexate—Vaginal infection—Esomeprazole—Barrett's esophagus	0.000542	0.00568	CcSEcCtD
Methotrexate—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.000519	0.00544	CcSEcCtD
Methotrexate—Neoplasm—Esomeprazole—Barrett's esophagus	0.000519	0.00544	CcSEcCtD
Methotrexate—Bladder pain—Esomeprazole—Barrett's esophagus	0.000519	0.00544	CcSEcCtD
Methotrexate—Neoplasm—Omeprazole—Barrett's esophagus	0.000519	0.00544	CcSEcCtD
Methotrexate—Urine output increased—Omeprazole—Barrett's esophagus	0.000519	0.00544	CcSEcCtD
Methotrexate—Bladder pain—Omeprazole—Barrett's esophagus	0.000519	0.00544	CcSEcCtD
Methotrexate—Urine output increased—Esomeprazole—Barrett's esophagus	0.000519	0.00544	CcSEcCtD
Methotrexate—Mouth ulceration—Omeprazole—Barrett's esophagus	0.000519	0.00544	CcSEcCtD
Methotrexate—Gynaecomastia—Omeprazole—Barrett's esophagus	0.000514	0.00538	CcSEcCtD
Methotrexate—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.000514	0.00538	CcSEcCtD
Methotrexate—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.000489	0.00512	CcSEcCtD
Methotrexate—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.000489	0.00512	CcSEcCtD
Methotrexate—SLCO1A2—digestive system—Barrett's esophagus	0.000485	0.0144	CbGeAlD
Methotrexate—Photosensitivity—Esomeprazole—Barrett's esophagus	0.000475	0.00497	CcSEcCtD
Methotrexate—Polyuria—Esomeprazole—Barrett's esophagus	0.000475	0.00497	CcSEcCtD
Methotrexate—Photosensitivity—Omeprazole—Barrett's esophagus	0.000475	0.00497	CcSEcCtD
Methotrexate—Polyuria—Omeprazole—Barrett's esophagus	0.000475	0.00497	CcSEcCtD
Methotrexate—ABCC4—digestive system—Barrett's esophagus	0.000466	0.0138	CbGeAlD
Methotrexate—Hepatic failure—Esomeprazole—Barrett's esophagus	0.000464	0.00486	CcSEcCtD
Methotrexate—Hepatic failure—Omeprazole—Barrett's esophagus	0.000464	0.00486	CcSEcCtD
Methotrexate—ABCC2—digestive system—Barrett's esophagus	0.000451	0.0134	CbGeAlD
Methotrexate—Visual disturbance—Omeprazole—Barrett's esophagus	0.00044	0.00461	CcSEcCtD
Methotrexate—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00044	0.00461	CcSEcCtD
Methotrexate—Osteoarthritis—Omeprazole—Barrett's esophagus	0.000417	0.00436	CcSEcCtD
Methotrexate—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.000417	0.00436	CcSEcCtD
Methotrexate—Irritability—Esomeprazole—Barrett's esophagus	0.000398	0.00417	CcSEcCtD
Methotrexate—Irritability—Omeprazole—Barrett's esophagus	0.000398	0.00417	CcSEcCtD
Methotrexate—Breast disorder—Esomeprazole—Barrett's esophagus	0.000377	0.00394	CcSEcCtD
Methotrexate—Breast disorder—Omeprazole—Barrett's esophagus	0.000377	0.00394	CcSEcCtD
Methotrexate—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000376	0.00393	CcSEcCtD
Methotrexate—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000376	0.00393	CcSEcCtD
Methotrexate—Asthma—Omeprazole—Barrett's esophagus	0.00036	0.00377	CcSEcCtD
Methotrexate—Asthma—Esomeprazole—Barrett's esophagus	0.00036	0.00377	CcSEcCtD
Methotrexate—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000353	0.0037	CcSEcCtD
Methotrexate—Pancreatitis—Omeprazole—Barrett's esophagus	0.000353	0.0037	CcSEcCtD
Methotrexate—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000342	0.00358	CcSEcCtD
Methotrexate—Pancytopenia—Omeprazole—Barrett's esophagus	0.000342	0.00358	CcSEcCtD
Methotrexate—Dysuria—Esomeprazole—Barrett's esophagus	0.000337	0.00353	CcSEcCtD
Methotrexate—Neutropenia—Esomeprazole—Barrett's esophagus	0.000337	0.00353	CcSEcCtD
Methotrexate—Dysuria—Omeprazole—Barrett's esophagus	0.000337	0.00353	CcSEcCtD
Methotrexate—Neutropenia—Omeprazole—Barrett's esophagus	0.000337	0.00353	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000335	0.00351	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000335	0.00351	CcSEcCtD
Methotrexate—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000332	0.00347	CcSEcCtD
Methotrexate—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000332	0.00347	CcSEcCtD
Methotrexate—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000329	0.00344	CcSEcCtD
Methotrexate—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000329	0.00344	CcSEcCtD
Methotrexate—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000321	0.00336	CcSEcCtD
Methotrexate—Infestation—Esomeprazole—Barrett's esophagus	0.000321	0.00336	CcSEcCtD
Methotrexate—Infestation NOS—Omeprazole—Barrett's esophagus	0.000321	0.00336	CcSEcCtD
Methotrexate—Infestation—Omeprazole—Barrett's esophagus	0.000321	0.00336	CcSEcCtD
Methotrexate—Depression—Omeprazole—Barrett's esophagus	0.00032	0.00335	CcSEcCtD
Methotrexate—Depression—Esomeprazole—Barrett's esophagus	0.00032	0.00335	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000319	0.00333	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000319	0.00333	CcSEcCtD
Methotrexate—Renal failure—Esomeprazole—Barrett's esophagus	0.000316	0.00331	CcSEcCtD
Methotrexate—Renal failure—Omeprazole—Barrett's esophagus	0.000316	0.00331	CcSEcCtD
Methotrexate—Stomatitis—Esomeprazole—Barrett's esophagus	0.000313	0.00328	CcSEcCtD
Methotrexate—Stomatitis—Omeprazole—Barrett's esophagus	0.000313	0.00328	CcSEcCtD
Methotrexate—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000312	0.00327	CcSEcCtD
Methotrexate—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000312	0.00327	CcSEcCtD
Methotrexate—Haematuria—Esomeprazole—Barrett's esophagus	0.000306	0.00321	CcSEcCtD
Methotrexate—Haematuria—Omeprazole—Barrett's esophagus	0.000306	0.00321	CcSEcCtD
Methotrexate—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000304	0.00318	CcSEcCtD
Methotrexate—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000304	0.00318	CcSEcCtD
Methotrexate—Epistaxis—Esomeprazole—Barrett's esophagus	0.000303	0.00317	CcSEcCtD
Methotrexate—Epistaxis—Omeprazole—Barrett's esophagus	0.000303	0.00317	CcSEcCtD
Methotrexate—Agranulocytosis—Omeprazole—Barrett's esophagus	0.0003	0.00314	CcSEcCtD
Methotrexate—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.0003	0.00314	CcSEcCtD
Methotrexate—Hepatitis—Omeprazole—Barrett's esophagus	0.000288	0.00302	CcSEcCtD
Methotrexate—Hepatitis—Esomeprazole—Barrett's esophagus	0.000288	0.00302	CcSEcCtD
Methotrexate—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000286	0.003	CcSEcCtD
Methotrexate—Pharyngitis—Omeprazole—Barrett's esophagus	0.000286	0.003	CcSEcCtD
Methotrexate—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000285	0.00298	CcSEcCtD
Methotrexate—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000285	0.00298	CcSEcCtD
Methotrexate—Urethral disorder—Omeprazole—Barrett's esophagus	0.000283	0.00296	CcSEcCtD
Methotrexate—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000283	0.00296	CcSEcCtD
Methotrexate—Visual impairment—Omeprazole—Barrett's esophagus	0.000278	0.00291	CcSEcCtD
Methotrexate—Visual impairment—Esomeprazole—Barrett's esophagus	0.000278	0.00291	CcSEcCtD
Methotrexate—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000273	0.00285	CcSEcCtD
Methotrexate—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000273	0.00285	CcSEcCtD
Methotrexate—Eye disorder—Esomeprazole—Barrett's esophagus	0.00027	0.00282	CcSEcCtD
Methotrexate—Eye disorder—Omeprazole—Barrett's esophagus	0.00027	0.00282	CcSEcCtD
Methotrexate—Tinnitus—Esomeprazole—Barrett's esophagus	0.000269	0.00281	CcSEcCtD
Methotrexate—Tinnitus—Omeprazole—Barrett's esophagus	0.000269	0.00281	CcSEcCtD
Methotrexate—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000261	0.00273	CcSEcCtD
Methotrexate—Immune system disorder—Omeprazole—Barrett's esophagus	0.000261	0.00273	CcSEcCtD
Methotrexate—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00026	0.00272	CcSEcCtD
Methotrexate—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00026	0.00272	CcSEcCtD
Methotrexate—Chills—Omeprazole—Barrett's esophagus	0.000259	0.00271	CcSEcCtD
Methotrexate—Chills—Esomeprazole—Barrett's esophagus	0.000259	0.00271	CcSEcCtD
Methotrexate—Alopecia—Omeprazole—Barrett's esophagus	0.000255	0.00267	CcSEcCtD
Methotrexate—Alopecia—Esomeprazole—Barrett's esophagus	0.000255	0.00267	CcSEcCtD
Methotrexate—Mental disorder—Omeprazole—Barrett's esophagus	0.000253	0.00264	CcSEcCtD
Methotrexate—Mental disorder—Esomeprazole—Barrett's esophagus	0.000253	0.00264	CcSEcCtD
Methotrexate—Malnutrition—Esomeprazole—Barrett's esophagus	0.000251	0.00263	CcSEcCtD
Methotrexate—Malnutrition—Omeprazole—Barrett's esophagus	0.000251	0.00263	CcSEcCtD
Methotrexate—Dysgeusia—Omeprazole—Barrett's esophagus	0.000246	0.00257	CcSEcCtD
Methotrexate—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000246	0.00257	CcSEcCtD
Methotrexate—Back pain—Esomeprazole—Barrett's esophagus	0.000243	0.00254	CcSEcCtD
Methotrexate—Back pain—Omeprazole—Barrett's esophagus	0.000243	0.00254	CcSEcCtD
Methotrexate—Vision blurred—Omeprazole—Barrett's esophagus	0.000237	0.00248	CcSEcCtD
Methotrexate—Vision blurred—Esomeprazole—Barrett's esophagus	0.000237	0.00248	CcSEcCtD
Methotrexate—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000233	0.00244	CcSEcCtD
Methotrexate—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000233	0.00244	CcSEcCtD
Methotrexate—Anaemia—Omeprazole—Barrett's esophagus	0.000232	0.00243	CcSEcCtD
Methotrexate—Anaemia—Esomeprazole—Barrett's esophagus	0.000232	0.00243	CcSEcCtD
Methotrexate—Malaise—Omeprazole—Barrett's esophagus	0.000226	0.00237	CcSEcCtD
Methotrexate—Malaise—Esomeprazole—Barrett's esophagus	0.000226	0.00237	CcSEcCtD
Methotrexate—Vertigo—Esomeprazole—Barrett's esophagus	0.000226	0.00236	CcSEcCtD
Methotrexate—Vertigo—Omeprazole—Barrett's esophagus	0.000226	0.00236	CcSEcCtD
Methotrexate—Leukopenia—Esomeprazole—Barrett's esophagus	0.000225	0.00235	CcSEcCtD
Methotrexate—Leukopenia—Omeprazole—Barrett's esophagus	0.000225	0.00235	CcSEcCtD
Methotrexate—Cough—Omeprazole—Barrett's esophagus	0.000219	0.00229	CcSEcCtD
Methotrexate—Cough—Esomeprazole—Barrett's esophagus	0.000219	0.00229	CcSEcCtD
Methotrexate—Arthralgia—Omeprazole—Barrett's esophagus	0.000214	0.00224	CcSEcCtD
Methotrexate—Myalgia—Omeprazole—Barrett's esophagus	0.000214	0.00224	CcSEcCtD
Methotrexate—Chest pain—Omeprazole—Barrett's esophagus	0.000214	0.00224	CcSEcCtD
Methotrexate—Arthralgia—Esomeprazole—Barrett's esophagus	0.000214	0.00224	CcSEcCtD
Methotrexate—Chest pain—Esomeprazole—Barrett's esophagus	0.000214	0.00224	CcSEcCtD
Methotrexate—Myalgia—Esomeprazole—Barrett's esophagus	0.000214	0.00224	CcSEcCtD
Methotrexate—ABCB1—epithelium—Barrett's esophagus	0.000213	0.00633	CbGeAlD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000212	0.00222	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000212	0.00222	CcSEcCtD
Methotrexate—Discomfort—Omeprazole—Barrett's esophagus	0.000211	0.00221	CcSEcCtD
Methotrexate—Discomfort—Esomeprazole—Barrett's esophagus	0.000211	0.00221	CcSEcCtD
Methotrexate—Confusional state—Esomeprazole—Barrett's esophagus	0.000207	0.00216	CcSEcCtD
Methotrexate—Confusional state—Omeprazole—Barrett's esophagus	0.000207	0.00216	CcSEcCtD
Methotrexate—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000205	0.00214	CcSEcCtD
Methotrexate—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000205	0.00214	CcSEcCtD
Methotrexate—Infection—Omeprazole—Barrett's esophagus	0.000204	0.00213	CcSEcCtD
Methotrexate—Infection—Esomeprazole—Barrett's esophagus	0.000204	0.00213	CcSEcCtD
Methotrexate—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000201	0.0021	CcSEcCtD
Methotrexate—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000201	0.0021	CcSEcCtD
Methotrexate—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000201	0.0021	CcSEcCtD
Methotrexate—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000201	0.0021	CcSEcCtD
Methotrexate—Skin disorder—Omeprazole—Barrett's esophagus	0.000199	0.00208	CcSEcCtD
Methotrexate—Skin disorder—Esomeprazole—Barrett's esophagus	0.000199	0.00208	CcSEcCtD
Methotrexate—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000198	0.00207	CcSEcCtD
Methotrexate—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000198	0.00207	CcSEcCtD
Methotrexate—Anorexia—Omeprazole—Barrett's esophagus	0.000195	0.00204	CcSEcCtD
Methotrexate—Anorexia—Esomeprazole—Barrett's esophagus	0.000195	0.00204	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000187	0.00195	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000187	0.00195	CcSEcCtD
Methotrexate—Insomnia—Omeprazole—Barrett's esophagus	0.000185	0.00194	CcSEcCtD
Methotrexate—Insomnia—Esomeprazole—Barrett's esophagus	0.000185	0.00194	CcSEcCtD
Methotrexate—Paraesthesia—Omeprazole—Barrett's esophagus	0.000184	0.00193	CcSEcCtD
Methotrexate—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000184	0.00193	CcSEcCtD
Methotrexate—ABCC1—S1P1 pathway—PTGS2—Barrett's esophagus	0.000183	0.00676	CbGpPWpGaD
Methotrexate—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000183	0.00191	CcSEcCtD
Methotrexate—Dyspnoea—Omeprazole—Barrett's esophagus	0.000183	0.00191	CcSEcCtD
Methotrexate—Somnolence—Esomeprazole—Barrett's esophagus	0.000182	0.00191	CcSEcCtD
Methotrexate—Somnolence—Omeprazole—Barrett's esophagus	0.000182	0.00191	CcSEcCtD
Methotrexate—Dyspepsia—Omeprazole—Barrett's esophagus	0.00018	0.00189	CcSEcCtD
Methotrexate—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00018	0.00189	CcSEcCtD
Methotrexate—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	0.000179	0.0066	CbGpPWpGaD
Methotrexate—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000178	0.00186	CcSEcCtD
Methotrexate—Decreased appetite—Omeprazole—Barrett's esophagus	0.000178	0.00186	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000177	0.00185	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000177	0.00185	CcSEcCtD
Methotrexate—Fatigue—Esomeprazole—Barrett's esophagus	0.000177	0.00185	CcSEcCtD
Methotrexate—Fatigue—Omeprazole—Barrett's esophagus	0.000177	0.00185	CcSEcCtD
Methotrexate—Pain—Esomeprazole—Barrett's esophagus	0.000175	0.00183	CcSEcCtD
Methotrexate—Pain—Omeprazole—Barrett's esophagus	0.000175	0.00183	CcSEcCtD
Methotrexate—ABCC10—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000172	0.00635	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000172	0.00635	CbGpPWpGaD
Methotrexate—MTHFR—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.00017	0.00628	CbGpPWpGaD
Methotrexate—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000169	0.00177	CcSEcCtD
Methotrexate—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000169	0.00177	CcSEcCtD
Methotrexate—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000168	0.00175	CcSEcCtD
Methotrexate—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000168	0.00175	CcSEcCtD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000163	0.00602	CbGpPWpGaD
Methotrexate—Urticaria—Esomeprazole—Barrett's esophagus	0.000163	0.0017	CcSEcCtD
Methotrexate—Urticaria—Omeprazole—Barrett's esophagus	0.000163	0.0017	CcSEcCtD
Methotrexate—ABCB1—digestive system—Barrett's esophagus	0.000162	0.00482	CbGeAlD
Methotrexate—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000162	0.0017	CcSEcCtD
Methotrexate—Body temperature increased—Omeprazole—Barrett's esophagus	0.000162	0.0017	CcSEcCtD
Methotrexate—Abdominal pain—Omeprazole—Barrett's esophagus	0.000162	0.0017	CcSEcCtD
Methotrexate—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000162	0.0017	CcSEcCtD
Methotrexate—ABCC11—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000159	0.00587	CbGpPWpGaD
Methotrexate—SLCO1C1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000157	0.0058	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000155	0.00574	CbGpPWpGaD
Methotrexate—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000151	0.00158	CcSEcCtD
Methotrexate—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000151	0.00158	CcSEcCtD
Methotrexate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000148	0.00546	CbGpPWpGaD
Methotrexate—Asthenia—Omeprazole—Barrett's esophagus	0.000147	0.00154	CcSEcCtD
Methotrexate—Asthenia—Esomeprazole—Barrett's esophagus	0.000147	0.00154	CcSEcCtD
Methotrexate—Pruritus—Esomeprazole—Barrett's esophagus	0.000145	0.00152	CcSEcCtD
Methotrexate—Pruritus—Omeprazole—Barrett's esophagus	0.000145	0.00152	CcSEcCtD
Methotrexate—Diarrhoea—Omeprazole—Barrett's esophagus	0.00014	0.00147	CcSEcCtD
Methotrexate—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00014	0.00147	CcSEcCtD
Methotrexate—MTHFR—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000139	0.00515	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—RELA—Barrett's esophagus	0.000138	0.00511	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—PTGES—Barrett's esophagus	0.000136	0.00503	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000136	0.00502	CbGpPWpGaD
Methotrexate—Dizziness—Omeprazole—Barrett's esophagus	0.000136	0.00142	CcSEcCtD
Methotrexate—Dizziness—Esomeprazole—Barrett's esophagus	0.000136	0.00142	CcSEcCtD
Methotrexate—SLC46A1—Folate Metabolism—TP53—Barrett's esophagus	0.000133	0.0049	CbGpPWpGaD
Methotrexate—ABCC4—Ectoderm Differentiation—BMP4—Barrett's esophagus	0.000132	0.00486	CbGpPWpGaD
Methotrexate—Vomiting—Esomeprazole—Barrett's esophagus	0.00013	0.00136	CcSEcCtD
Methotrexate—Vomiting—Omeprazole—Barrett's esophagus	0.00013	0.00136	CcSEcCtD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00013	0.00481	CbGpPWpGaD
Methotrexate—Rash—Omeprazole—Barrett's esophagus	0.000129	0.00135	CcSEcCtD
Methotrexate—Rash—Esomeprazole—Barrett's esophagus	0.000129	0.00135	CcSEcCtD
Methotrexate—Dermatitis—Esomeprazole—Barrett's esophagus	0.000129	0.00135	CcSEcCtD
Methotrexate—Dermatitis—Omeprazole—Barrett's esophagus	0.000129	0.00135	CcSEcCtD
Methotrexate—Headache—Esomeprazole—Barrett's esophagus	0.000128	0.00134	CcSEcCtD
Methotrexate—Headache—Omeprazole—Barrett's esophagus	0.000128	0.00134	CcSEcCtD
Methotrexate—DHFR—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000124	0.00457	CbGpPWpGaD
Methotrexate—ABCC4—Platelet degranulation—HGF—Barrett's esophagus	0.000123	0.00456	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—RELA—Barrett's esophagus	0.000123	0.00454	CbGpPWpGaD
Methotrexate—Nausea—Esomeprazole—Barrett's esophagus	0.000122	0.00127	CcSEcCtD
Methotrexate—Nausea—Omeprazole—Barrett's esophagus	0.000122	0.00127	CcSEcCtD
Methotrexate—DHFR—E2F transcription factor network—CDKN2A—Barrett's esophagus	0.000118	0.00435	CbGpPWpGaD
Methotrexate—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000118	0.00434	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PTGES—Barrett's esophagus	0.000116	0.00428	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PTGES—Barrett's esophagus	0.000116	0.00428	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.00011	0.00406	CbGpPWpGaD
Methotrexate—TYMS—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000108	0.00399	CbGpPWpGaD
Methotrexate—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	0.000108	0.00398	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000107	0.00395	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000105	0.00389	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000105	0.00389	CbGpPWpGaD
Methotrexate—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	0.000105	0.00389	CbGpPWpGaD
Methotrexate—SLC22A7—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000104	0.00385	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—CYP26A1—Barrett's esophagus	0.000103	0.00382	CbGpPWpGaD
Methotrexate—SLC22A11—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000103	0.00381	CbGpPWpGaD
Methotrexate—TYMS—E2F transcription factor network—CDKN2A—Barrett's esophagus	0.000103	0.0038	CbGpPWpGaD
Methotrexate—SLC16A1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000101	0.00374	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.99e-05	0.00369	CbGpPWpGaD
Methotrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	9.58e-05	0.00354	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.53e-05	0.00352	CbGpPWpGaD
Methotrexate—SLC22A7—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	9.37e-05	0.00346	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTGES—Barrett's esophagus	9.03e-05	0.00333	CbGpPWpGaD
Methotrexate—ABCC3—Fluoropyrimidine Activity—TP53—Barrett's esophagus	8.95e-05	0.0033	CbGpPWpGaD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	8.9e-05	0.00329	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—SLC9A1—Barrett's esophagus	8.89e-05	0.00328	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—CYP26A1—Barrett's esophagus	8.79e-05	0.00324	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—CYP26A1—Barrett's esophagus	8.79e-05	0.00324	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.7e-05	0.00321	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	8.56e-05	0.00316	CbGpPWpGaD
Methotrexate—ABCC1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.45e-05	0.00312	CbGpPWpGaD
Methotrexate—ABCC4—Fluoropyrimidine Activity—TP53—Barrett's esophagus	8.41e-05	0.00311	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	8.39e-05	0.0031	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTGES—Barrett's esophagus	8.26e-05	0.00305	CbGpPWpGaD
Methotrexate—ABCC3—NRF2 pathway—HGF—Barrett's esophagus	8.11e-05	0.003	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—TP53—Barrett's esophagus	8.01e-05	0.00296	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	7.98e-05	0.00295	CbGpPWpGaD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	7.87e-05	0.00291	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.85e-05	0.0029	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	7.77e-05	0.00287	CbGpPWpGaD
Methotrexate—ABCC4—NRF2 pathway—HGF—Barrett's esophagus	7.63e-05	0.00282	CbGpPWpGaD
Methotrexate—FPGS—Disease—SLC9A1—Barrett's esophagus	7.56e-05	0.00279	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—SLC9A1—Barrett's esophagus	7.45e-05	0.00275	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	7.38e-05	0.00272	CbGpPWpGaD
Methotrexate—DHFR—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	7.21e-05	0.00266	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—TP53—Barrett's esophagus	7.11e-05	0.00263	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	6.99e-05	0.00258	CbGpPWpGaD
Methotrexate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	6.95e-05	0.00257	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CYP26A1—Barrett's esophagus	6.84e-05	0.00253	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.84e-05	0.00253	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.66e-05	0.00246	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	6.57e-05	0.00243	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.53e-05	0.00241	CbGpPWpGaD
Methotrexate—ABCC2—NRF2 pathway—HGF—Barrett's esophagus	6.43e-05	0.00238	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—SLC9A1—Barrett's esophagus	6.33e-05	0.00234	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—SLC9A1—Barrett's esophagus	6.33e-05	0.00234	CbGpPWpGaD
Methotrexate—TYMS—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	6.29e-05	0.00232	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CYP26A1—Barrett's esophagus	6.26e-05	0.00231	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.26e-05	0.00231	CbGpPWpGaD
Methotrexate—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	6.17e-05	0.00228	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.15e-05	0.00227	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	5.98e-05	0.00221	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—SLC9A1—Barrett's esophagus	5.89e-05	0.00218	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	5.87e-05	0.00217	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.85e-05	0.00216	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.8e-05	0.00214	CbGpPWpGaD
Methotrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	5.7e-05	0.00211	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—HGF—Barrett's esophagus	5.59e-05	0.00206	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	5.48e-05	0.00202	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGES—Barrett's esophagus	5.45e-05	0.00201	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.45e-05	0.00201	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—PPARG—Barrett's esophagus	5.44e-05	0.00201	CbGpPWpGaD
Methotrexate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	5.42e-05	0.002	CbGpPWpGaD
Methotrexate—PGD—Disease—SLC9A1—Barrett's esophagus	5.39e-05	0.00199	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGES—Barrett's esophagus	5.32e-05	0.00197	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	5.32e-05	0.00196	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.28e-05	0.00195	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.25e-05	0.00194	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.22e-05	0.00193	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.14e-05	0.0019	CbGpPWpGaD
Methotrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	4.98e-05	0.00184	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	4.96e-05	0.00183	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—SLC9A1—Barrett's esophagus	4.93e-05	0.00182	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGES—Barrett's esophagus	4.84e-05	0.00179	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.76e-05	0.00176	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	4.65e-05	0.00172	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	4.59e-05	0.00169	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.52e-05	0.00167	CbGpPWpGaD
Methotrexate—PGD—Metabolism—SLC9A1—Barrett's esophagus	4.51e-05	0.00167	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	4.46e-05	0.00165	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGES—Barrett's esophagus	4.41e-05	0.00163	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGES—Barrett's esophagus	4.23e-05	0.00156	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—APC—Barrett's esophagus	4.21e-05	0.00155	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CYP26A1—Barrett's esophagus	4.13e-05	0.00152	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.08e-05	0.00151	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CYP26A1—Barrett's esophagus	4.03e-05	0.00149	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4e-05	0.00148	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGES—Barrett's esophagus	3.88e-05	0.00143	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.84e-05	0.00142	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—HGF—Barrett's esophagus	3.79e-05	0.0014	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—RELA—Barrett's esophagus	3.78e-05	0.0014	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CYP26A1—Barrett's esophagus	3.67e-05	0.00136	CbGpPWpGaD
Methotrexate—FPGS—Disease—APC—Barrett's esophagus	3.58e-05	0.00132	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SLC9A1—Barrett's esophagus	3.56e-05	0.00131	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.55e-05	0.00131	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGES—Barrett's esophagus	3.5e-05	0.00129	CbGpPWpGaD
Methotrexate—AOX1—Disease—SLC9A1—Barrett's esophagus	3.47e-05	0.00128	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	3.42e-05	0.00126	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—PPARG—Barrett's esophagus	3.4e-05	0.00126	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CYP26A1—Barrett's esophagus	3.34e-05	0.00123	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	3.34e-05	0.00123	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.34e-05	0.00123	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.23e-05	0.00119	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CYP26A1—Barrett's esophagus	3.2e-05	0.00118	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.2e-05	0.00118	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—PTGS2—Barrett's esophagus	3.19e-05	0.00118	CbGpPWpGaD
Methotrexate—DHFR—Disease—SLC9A1—Barrett's esophagus	3.16e-05	0.00117	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGES—Barrett's esophagus	3.05e-05	0.00112	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.04e-05	0.00112	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	3e-05	0.00111	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SLC9A1—Barrett's esophagus	2.98e-05	0.0011	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYP26A1—Barrett's esophagus	2.94e-05	0.00108	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	2.92e-05	0.00108	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SLC9A1—Barrett's esophagus	2.91e-05	0.00107	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PPARG—Barrett's esophagus	2.89e-05	0.00107	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PPARG—Barrett's esophagus	2.89e-05	0.00107	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	2.83e-05	0.00105	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—HGF—Barrett's esophagus	2.82e-05	0.00104	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	2.81e-05	0.00104	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—APC—Barrett's esophagus	2.79e-05	0.00103	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGES—Barrett's esophagus	2.74e-05	0.00101	CbGpPWpGaD
Methotrexate—FPGS—Disease—PTGS2—Barrett's esophagus	2.72e-05	0.001	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	2.7e-05	0.000998	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—PTGS2—Barrett's esophagus	2.67e-05	0.000988	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.65e-05	0.00098	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYP26A1—Barrett's esophagus	2.65e-05	0.000979	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SLC9A1—Barrett's esophagus	2.65e-05	0.000977	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	2.64e-05	0.000977	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGES—Barrett's esophagus	2.6e-05	0.000962	CbGpPWpGaD
Methotrexate—PGD—Disease—APC—Barrett's esophagus	2.55e-05	0.000941	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—TP53—Barrett's esophagus	2.55e-05	0.00094	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	2.48e-05	0.000916	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	2.48e-05	0.000915	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGES—Barrett's esophagus	2.41e-05	0.00089	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SLC9A1—Barrett's esophagus	2.41e-05	0.00089	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—CDKN2A—Barrett's esophagus	2.36e-05	0.000873	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SLC9A1—Barrett's esophagus	2.31e-05	0.000852	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP26A1—Barrett's esophagus	2.31e-05	0.000852	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	2.31e-05	0.000852	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PTGS2—Barrett's esophagus	2.27e-05	0.00084	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PTGS2—Barrett's esophagus	2.27e-05	0.00084	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PPARG—Barrett's esophagus	2.25e-05	0.000832	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—Barrett's esophagus	2.19e-05	0.000807	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.17e-05	0.000801	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SLC9A1—Barrett's esophagus	2.12e-05	0.000782	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PTGS2—Barrett's esophagus	2.12e-05	0.000781	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP26A1—Barrett's esophagus	2.08e-05	0.000767	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—CDKN2A—Barrett's esophagus	2.06e-05	0.000762	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PPARG—Barrett's esophagus	2.06e-05	0.000761	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP26A1—Barrett's esophagus	1.97e-05	0.000729	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.96e-05	0.000723	CbGpPWpGaD
Methotrexate—PGD—Disease—PTGS2—Barrett's esophagus	1.93e-05	0.000714	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SLC9A1—Barrett's esophagus	1.91e-05	0.000706	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	1.83e-05	0.000675	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	1.81e-05	0.000669	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SLC9A1—Barrett's esophagus	1.79e-05	0.00066	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTGS2—Barrett's esophagus	1.77e-05	0.000654	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	1.74e-05	0.000641	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.71e-05	0.00063	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.71e-05	0.00063	CbGpPWpGaD
Methotrexate—MTHFR—Disease—APC—Barrett's esophagus	1.68e-05	0.000621	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SLC9A1—Barrett's esophagus	1.66e-05	0.000614	CbGpPWpGaD
Methotrexate—AOX1—Disease—APC—Barrett's esophagus	1.64e-05	0.000606	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTGS2—Barrett's esophagus	1.62e-05	0.000598	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.54e-05	0.000569	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.53e-05	0.000567	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	1.52e-05	0.000562	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC9A1—Barrett's esophagus	1.5e-05	0.000553	CbGpPWpGaD
Methotrexate—DHFR—Disease—APC—Barrett's esophagus	1.49e-05	0.000552	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGES—Barrett's esophagus	1.49e-05	0.000549	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.46e-05	0.000538	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC9A1—Barrett's esophagus	1.42e-05	0.000525	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	1.38e-05	0.000508	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PPARG—Barrett's esophagus	1.36e-05	0.000502	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.34e-05	0.000495	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PPARG—Barrett's esophagus	1.33e-05	0.00049	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	1.32e-05	0.000486	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—Barrett's esophagus	1.32e-05	0.000486	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGES—Barrett's esophagus	1.3e-05	0.000481	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HGF—Barrett's esophagus	1.28e-05	0.000472	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTGS2—Barrett's esophagus	1.28e-05	0.000471	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—Barrett's esophagus	1.27e-05	0.000469	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTGS2—Barrett's esophagus	1.25e-05	0.00046	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PPARG—Barrett's esophagus	1.21e-05	0.000446	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.21e-05	0.000446	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—Barrett's esophagus	1.15e-05	0.000424	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.15e-05	0.000424	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—Barrett's esophagus	1.13e-05	0.000419	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP26A1—Barrett's esophagus	1.13e-05	0.000416	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PPARG—Barrett's esophagus	1.1e-05	0.000406	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—Barrett's esophagus	1.07e-05	0.000395	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARG—Barrett's esophagus	1.05e-05	0.000389	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—Barrett's esophagus	1.04e-05	0.000386	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	9.88e-06	0.000365	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARG—Barrett's esophagus	9.67e-06	0.000357	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—Barrett's esophagus	9.5e-06	0.000351	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—Barrett's esophagus	9.47e-06	0.00035	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARG—Barrett's esophagus	8.72e-06	0.000322	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—Barrett's esophagus	8.65e-06	0.000319	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APC—Barrett's esophagus	8.46e-06	0.000312	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	8.33e-06	0.000308	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—Barrett's esophagus	8.29e-06	0.000306	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	8.19e-06	0.000302	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC9A1—Barrett's esophagus	8.13e-06	0.0003	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—Barrett's esophagus	7.6e-06	0.000281	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARG—Barrett's esophagus	7.6e-06	0.00028	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	7.12e-06	0.000263	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—Barrett's esophagus	6.86e-06	0.000253	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARG—Barrett's esophagus	6.83e-06	0.000252	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	6.56e-06	0.000242	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARG—Barrett's esophagus	6.5e-06	0.00024	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—Barrett's esophagus	6.42e-06	0.000237	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARG—Barrett's esophagus	6.01e-06	0.000222	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—Barrett's esophagus	5.97e-06	0.000221	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—Barrett's esophagus	5.38e-06	0.000199	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—Barrett's esophagus	5.11e-06	0.000189	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—Barrett's esophagus	4.73e-06	0.000175	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—Barrett's esophagus	4.29e-06	0.000158	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARG—Barrett's esophagus	3.71e-06	0.000137	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARG—Barrett's esophagus	3.25e-06	0.00012	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—Barrett's esophagus	2.92e-06	0.000108	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—Barrett's esophagus	2.56e-06	9.44e-05	CbGpPWpGaD
